SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-027148
Filing Date
2012-05-09
Accepted
2012-05-09 16:02:08
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v311572_10q.htm 10-Q 217396
2 EXHIBIT 31.1 v311572_ex31-1.htm EX-31.1 8553
3 EXHIBIT 31.2 v311572_ex31-2.htm EX-31.2 8627
4 EXHIBIT 32.1 v311572_ex32-1.htm EX-32.1 3594
5 EXHIBIT 32.2 v311572_ex32-2.htm EX-32.2 3577
  Complete submission text file 0001144204-12-027148.txt   1302283

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vtus-20120331.xml EX-101.INS 104389
7 XBRL TAXONOMY EXTENSION SCHEMA vtus-20120331.xsd EX-101.SCH 12061
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vtus-20120331_cal.xml EX-101.CAL 16655
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtus-20120331_def.xml EX-101.DEF 77793
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtus-20120331_lab.xml EX-101.LAB 116974
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtus-20120331_pre.xml EX-101.PRE 90447
Mailing Address 99 HUDSON STREET 5TH FLOOR NEW YORK NY 10013
Business Address 99 HUDSON STREET 5TH FLOOR NEW YORK NY 10013 (212) 554-4388
VENTRUS BIOSCIENCES INC (Filer) CIK: 0001426800 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-35005 | Film No.: 12825671
SIC: 2834 Pharmaceutical Preparations